BIOPHARMA MANUFACTURING: ELIMINATING DEPENDENCE ON IMPORTS
Indigenous manufacture of biopharmaceuticals is severely limited in Africa which depends on imports for nearly 80% of its requirements. The foreign companies, who have developed vaccines for COVID-19, are enabling the Africa Union to launch a platform for partnerships which augurs well for drug production in Africa. The manufacturing enterprises will discuss the impediments to establishment and growth and how they can be addressed strategically in the future.
Dr. Ranjana Pathak, Global Quality, Medical Affairs and Pharmacovigilance, Dr. Reddy’s Laboratories
BioNTech (Waiting Confirmation)
Moderna (Waiting Confirmation)
Unizima (UNIVERCELLS) (Waiting Confirmation)
Aspen Pharmacare (Waiting Conformation)
Moderator: Franck Toussaint, Managing Director, BSMA Europe
AFRICA UNION COLLABORATION TO COMBAT INFECTIOUS DISEASES
Since the emergence of the Ebola virus in 1976, periodic outbreaks have been a global health challenge, with COVID-19 as an ongoing one. The African regions bear an immense burden of infectious diseases, particularly that of HIV aids, tuberculosis and malaria, and they are an obstacle to human development. HIV aids, tuberculosis and malaria, kill more than 3 million people in the region every year. Medical scientists from various countries will address successful practices for advocacy for greater national health systems; collaboration in research through joint scientific groups for the continent; greater information sharing among CDCs; combined purchasing of lab equipment, reagents and supplies; deployment of digital technology; and governmental policy alignment for accelerated adoption of solutions across the region.
Prof. Emmanuel Nakoune, Scientific Director, and Head of Hemorragic Fever Virus Lab, Institut Pasteur, Bangui, Central Africa Republic
Dr. Edgard Valery Adjogoua, Virologist, Department of Virus Epidemics, Institut Pasteur de Côte d’Ivoire
Dr Hervé Kadjo, Department of Epidemic Viruses, Respiratory Viruses Unit, National Influenza Centre, Pasteur Institute of Cote d’Ivoire
Dr. Shevin Jacob, Reader, Sepsis Research, Liverpool School of Tropical Medicine (LSTM) & Co-founder & Director, Walimu, Uganda
Dr. Nadine Rujeni, Associate Professor of Parasitology, National University of Rwanda
Moderator: Maurice Demanou, Consultant, Yellow Fever Regional Laboratory Coordinator for Africa, WHO